What is Lipo-C 121mg/mL (MCC Lipotropic Blend)?
Lipo-C 121mg/mL (Injectable MCC lipotropic blend) combines four synergistic lipotropic agents in a single injectable: Methionine — essential amino acid and methyl donor for hepatic lipid metabolism; Choline Chloride — phospholipid precursor and hepatoprotective lipotrope; L-Carnitine — mitochondrial fatty acid transporter for β-oxidation; Dexpanthenol (Vitamin B5 pro-drug) — CoA precursor supporting lipid metabolism. Combined lipotropic activity supports hepatic fat mobilisation and fatty acid oxidation research.
Research Applications
Hepatic Lipid Metabolism
Combined methionine + choline lipotropic activity — hepatic steatosis and fat mobilisation research
Mitochondrial Fatty Acid Oxidation
L-Carnitine β-oxidation augmented by CoA availability from Dexpanthenol
Choline Deficiency Models
Choline supplementation in NAFLD, hepatic fat accumulation, and phospholipid synthesis research
Weight Management Research
Multi-pathway lipotropic blend — fat mobilisation, oxidation, and hepatic export
CoA Pathway Research
Dexpanthenol → pantothenic acid → CoA — coenzyme A availability for lipid metabolism
Quick Specs
| Form | Injectable solution (lipotropic blend) |
| Total Concentration | 121mg/mL |
| Components | Methionine 15mg/mL · Choline Chloride 50mg/mL · L-Carnitine 50mg/mL · Dexpanthenol 5mg/mL · Cyanocobalamin (B12) 1mg/mL |
| Purity | ≥99% by HPLC — every batch |
| COA | Janoshik-independent, publicly verifiable |
| Vehicle | Sterile aqueous solution |
| Storage | 2–8°C | Protect from light |
| Shelf Life | 24 months (unopened) |
